Oasmia
  • About Oasmia
    • About Oasmia
    • Vision & goals
    • Our Technology
    • Production
    • History
    • Research & Development
    • Board of Directors
    • Management
    • Department Directors
  • Investor Relations
    • Investor Relations EU
      • Investor Relations EU
      • Press Releases
      • The share
        • The share
        • Shareholders
      • Current reports
      • Calendar
      • Corporate Governance
        • Corporate Governance
        • Board of Directors
          • Board of Directors
          • Chairman of the Board
          • Work plan for the Board of Directors
          • Audit committee
          • Remuneration committee
        • Management
        • Department Directors
        • Nomination committee
        • General Meetings
        • Warrant program
        • Articles of Association
        • Code of Business Conduct and Ethics
        • Auditor
        • Corporate Governance reports
      • Subscribe
    • Investor Relations US
  • Market
    • Market Human Health
    • Market Animal Health
  • Media
    • Media Contact
    • Press Releases
  • Contact
  • Career
  • sv
Navigation

Investor Relations

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Current Reports
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • Home /
  • Investors /
  • Governance Documents

Governance Documents

Name View Document

Code of Business Conduct and Ethics

Download Code of Business Conduct and Ethics

Articles of Association

Download Articles of Association
Facebook Facebook Twitter Twitter LinkedIn LinkedIn Google+ Google+ Email Email
Oasmia Pharmaceutical AB
Vallongatan 1
SE 752 28 Uppsala, Sweden
Tel +46 18 50 54 40
Fax +46 18 51 08 73
info@oasmia.com
Org no 556332-6676
Twitter Facebook
Copyright © 2010-2019 Oasmia